Search


Current filters:

Clear current filters  or Add more filters

View Option



Results 1-10 of 14 (Search time: 0.006 seconds).

  Implication of lipoprotein associated phospholipase A(2) activity in oxLDL uptake by macrophages (Journal article)

  Influence of high-density lipoprotein and paraoxonase-1 on platelet reactivity in patients with acute coronary syndromes receiving clopidogrel therapy (Journal article)

  Inhibition of platelet activation by peptide analogs of the beta(3)-intracellular domain of platelet integrin alpha(IIb)beta(3) conjugated to the cell-penetrating peptide Tat(48-60) (Journal article)

  PAF effects on MCP-1 and IL-6 secretion in U-937 monocytes in comparison with OxLDL and IL-1 beta effects (Journal article)

  A palmitoylated peptide, derived from the acidic carboxyl-terminal segment of the integrin IIb cytoplasmic domain, inhibits platelet activation (Journal article)

  Clopidogrel differentially affects platelet- mediated thrombosis and inflammatory response in patients with acute coronary syndromes (Journal article)

  The platelet hyporesponsiveness to clopidogrel in acute coronary syndrome patients treated with 75 mg/day clopidogrel may be overcome within 1 month of treatment (Journal article)

  Effect of clopidogrel besylate on platelet reactivity in patients with acute coronary syndromes. Comparison with clopidogrel hydrogen sulfate (Journal article)

  The effects of rosuvastatin alone or in combination with fenofibrate or omega 3 fatty acids on inflammation and oxidative stress in patients with mixed dyslipidemia (Journal article)

  Platelet-derived microparticles inhibit the oxidative modification of LDL possibly through their phosphatidylserine and plasmalogen content (Journal article)